CPhI Worldwide, organized by UBM (part of Informa PLC), has announced the finalists of the eagerly anticipated 2018 CPhI Pharma Awards.
This year’s edition features a record breaking number of entries, with over 250 from 174 participating companies across 17 categories, commending the innovations, technologies, and strategies driving pharma forward.
Such was the high caliber of entrants, 139 have been shortlisted, with the winners due to be announced during a live awards ceremony taking place at the luxurious Eurostars Madrid Tower Hotel on Tuesday October 9 – the opening day of CPhI Worldwide.
Innovations across flow chemistry, single-use technologies, drug delivery devices, contract services and packaging were amongst many shortlisted, with the judges concluding this was by far the highest ever standard of entries – further cementing 2018 as the year of innovation in pharma.
The awards for “Pharma company of the year”and “CEO of the year” will again be keenly sought as over 45,000 senior executives and 2500 companies attend at this year’s CPhI Worldwide.
To see the complete list of finalists, please visit https://awards.cphi.com/finalists/. The awards will be presented at the CPhI Awards Gala with over 350 guests in attendance.
To reserve a table for the CPhI Pharma Awards Gala, please visit https://awards.cphi.com/attend-the-gala/.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.